PD
BMY icon

Point72 (DIFC)’s Bristol-Myers Squibb BMY Stock Holding History

Point72 (DIFC)’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$4.84M Buy
+107,251
New +$5.01M 0.32% 80
2025
Q1 		– Sell
-160,842
Closed -$9.38M – 1688
2024
Q4 		$9.1M Buy
+160,842
New +$8.99M 0.33% 65
2024
Q3 		– Sell
-639,862
Closed -$30M – 1471
2024
Q2 		$26.6M Buy
+639,862
New +$28.6M 0.95% 8

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Point72 (DIFC)'s BMY Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in Bristol-Myers Squibb (BMY) in Q3 2025: 107,251 shares worth $4.84M. The stake represents 0.32% of the portfolio and ranks #80 among its holdings. This is a return to the name: Point72 (DIFC) previously reported a position in BMY as recently as Q4 2024.

Point72 (DIFC) first reported a position in BMY in Q2 2024 and has held it in 3 quarters since. The position peaked at $26.6M in Q2 2024. 2,274 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Point72 (DIFC) held 107,251 shares of Bristol-Myers Squibb worth $4.84M as of Q3 2025.
  • Bristol-Myers Squibb was a new Point72 (DIFC) position in Q3 2025.
  • Bristol-Myers Squibb made up 0.32% of Point72 (DIFC)'s portfolio in Q3 2025, its #80 holding.
  • Point72 (DIFC) first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 3 quarters since.
  • Point72 (DIFC)'s Bristol-Myers Squibb position peaked at $26.6M in Q2 2024.
  • 2,274 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.